Category Archives: Epidemiology and Determinants of Health

Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis

2023

Objectives: People living with HIV (PLWH) experience a greater risk of morbidity and mortality following COVID-19 infection, and poorer immunological responses to several vaccines. We explored existing evidence regarding the immunogenicity,...

Disparities in healthcare access and utilization among people living with HIV in China: A scoping review and meta-analysis

2023

Background Healthcare disparities hinder the goal of ending the HIV pandemic by 2030. This review aimed to understand the status of healthcare disparities among people living with HIV (PLWH) in...

The urban environment and disparities in sexual and reproductive health outcomes in the Global South: A scoping review

2023

By 2050, the Global South will contain three-quarters of the world’s urban inhabitants, yet no standardized categorizations of urban areas exist. This makes it challenging to compare sub-groups within cities....

Impact of mass media on HIV/AIDS stigma reduction: A systematic review and meta-analysis

2023

HIV-related stigma is a major barrier to HIV testing and care engagement. Despite efforts to use mass media to address HIV-related stigma, their impact on reducing HIV-related stigma remains unclear....

The impact of needle and syringe exchange programs on HIV-related risk behaviors in low- and middle-income countries: A systematic review and meta-analysis examining individual- versus community-level effects

2023

We conducted a systematic review and meta-analysis of the impact of needle and syringe exchange programs (NSP) on both individual- and community-level needle-sharing behaviors and other HIV-related outcomes in low-...

Communicable diseases prevalence among refugees and asylum seekers: Systematic review and meta-analysis

2023

BACKGROUND: Communicable diseases remain a significant global health issue. The increase in refugees and asylum seekers associated with conflicts may alter the burden of communicable diseases in host countries. We...

Behavioral and social interventions to promote optimal HIV prevention and care continua outcomes in the United States

2022

PURPOSE OF REVIEW: This review reports on trends in behavioral and social intervention research in the United States published over the past year (2020-2021) investigating HIV prevention and care outcomes,...

The innovative use of qualitative and mixed methods research to advance improvements along the HIV prevention and care continua

2022

PURPOSE OF REVIEW: Despite enormous advances in prevention and care modalities, HIV continues to burden populations around the globe and is largely driven by social and behavioral processes. Mixed methods...

From surviving to thriving: The current status of the behavioral, social, and psychological issues of aging with HIV

2022

PURPOSE OF REVIEW: Despite significant advances in knowledge regarding the biological and clinical issues related to aging with HIV, significantly less research has centered on related psychological, behavioral, and social...

Human papillomavirus infection among pregnant women living with HIV: A systematic review and meta-analysis

2022

BACKGROUND: In the general population, human papillomavirus (HPV) prevalence is reportedly increased during pregnancy, and emerging evidence suggests that it may be associated with adverse pregnancy outcomes. Women living with...

Performance of cardiovascular risk prediction models among people living with HIV: A systematic review and meta-analysis

2023

Importance  Extant data on the performance of cardiovascular disease (CVD) risk score models in people living with HIV have not been synthesized. Objective  To synthesize available data on the performance of the...

What factors are associated with willingness to use HIV pre-exposure prophylaxis (PrEP) among U.S. men who have sex with nen not on PrEP? A systematic review and meta-analysis

2023

Pre-exposure prophylaxis (PrEP), an antiretroviral medication to prevent HIV, is becoming more widely available in the United States since the Federal Drug Administration approved it in 2012. However, PrEP use...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!